Procyon Advisors LLC Increases Holdings in McKesson Corporation $MCK

Procyon Advisors LLC increased its stake in McKesson Corporation (NYSE:MCK) by 92.3% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 6,434 shares of the company’s stock after buying an additional 3,089 shares during the quarter. Procyon Advisors LLC’s holdings in McKesson were worth $5,278,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in MCK. Obsidian Personal Planning Solutions LLC grew its position in shares of McKesson by 2.9% in the 3rd quarter. Obsidian Personal Planning Solutions LLC now owns 426 shares of the company’s stock worth $346,000 after buying an additional 12 shares during the last quarter. IAM Advisory LLC increased its position in McKesson by 0.3% during the 3rd quarter. IAM Advisory LLC now owns 3,908 shares of the company’s stock valued at $3,019,000 after purchasing an additional 13 shares during the period. PDS Planning Inc raised its holdings in McKesson by 1.1% in the 3rd quarter. PDS Planning Inc now owns 1,209 shares of the company’s stock worth $934,000 after purchasing an additional 13 shares in the last quarter. Berkshire Asset Management LLC PA lifted its position in shares of McKesson by 4.6% in the 3rd quarter. Berkshire Asset Management LLC PA now owns 294 shares of the company’s stock worth $227,000 after purchasing an additional 13 shares during the period. Finally, Goldstein Advisors LLC lifted its position in shares of McKesson by 4.4% in the 3rd quarter. Goldstein Advisors LLC now owns 334 shares of the company’s stock worth $258,000 after purchasing an additional 14 shares during the period. Institutional investors own 85.07% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on MCK shares. JPMorgan Chase & Co. boosted their price target on shares of McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of McKesson in a report on Wednesday, December 10th. Raymond James Financial set a $970.00 target price on McKesson in a report on Thursday, March 5th. Morgan Stanley reissued an “overweight” rating and issued a $966.00 target price on shares of McKesson in a research report on Thursday, January 29th. Finally, Evercore restated an “outperform” rating on shares of McKesson in a research note on Thursday, March 5th. Thirteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $960.93.

Insider Activity at McKesson

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the company’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Maria Martinez sold 349 shares of the firm’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $939.87, for a total transaction of $328,014.63. Following the sale, the director directly owned 301 shares in the company, valued at approximately $282,900.87. The trade was a 53.69% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 3,868 shares of company stock valued at $3,743,820 over the last three months. 0.08% of the stock is owned by insiders.

McKesson Stock Performance

Shares of McKesson stock opened at $888.28 on Friday. The company has a 50-day simple moving average of $903.68 and a two-hundred day simple moving average of $833.49. The stock has a market capitalization of $108.81 billion, a PE ratio of 25.55, a price-to-earnings-growth ratio of 1.43 and a beta of 0.38. McKesson Corporation has a 52-week low of $637.00 and a 52-week high of $999.00.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. The firm had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, equities research analysts forecast that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be issued a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson’s dividend payout ratio is presently 9.43%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.